Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609

Watchlist Manager
Shanghai HeartCare Medical Technology Corp Ltd Logo
Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609
Watchlist
Price: 22.55 HKD -5.85% Market Closed
Market Cap: 875.7m HKD
Have any thoughts about
Shanghai HeartCare Medical Technology Corp Ltd?
Write Note

Shanghai HeartCare Medical Technology Corp Ltd
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shanghai HeartCare Medical Technology Corp Ltd
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609
Retained Earnings
ÂĄ1.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Retained Earnings
ÂĄ1.1B
CAGR 3-Years
66%
CAGR 5-Years
54%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Retained Earnings
ÂĄ9.2B
CAGR 3-Years
17%
CAGR 5-Years
23%
CAGR 10-Years
24%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Retained Earnings
ÂĄ31B
CAGR 3-Years
21%
CAGR 5-Years
31%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Retained Earnings
ÂĄ2.7B
CAGR 3-Years
10%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Retained Earnings
ÂĄ4.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Shanghai HeartCare Medical Technology Corp Ltd
Glance View

Market Cap
875.7m HKD
Industry
Health Care

Shanghai Heartcare Medical Technology Corp. Ltd. engages in the research, development, manufacture, and sale of neuro-interventional medical devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-08-20. The firm's product portfolio includes both neuro-interventional and cardiac medical devices, and its main products are CaptorTM thrombectomy device (Captor) and left atrial appendage occluder. The firm's product portfolio extends from the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis to the treatment of hemorrhagic stroke. The firm's other products include the balloon guiding catheter, the ExtraFlex distal access catheter and SupSelek microcatheter. The firm distributes its products within the domestic market.

Intrinsic Value
33.74 HKD
Undervaluation 33%
Intrinsic Value
Price

See Also

What is Shanghai HeartCare Medical Technology Corp Ltd's Retained Earnings?
Retained Earnings
1.1B CNY

Based on the financial report for Dec 31, 2023, Shanghai HeartCare Medical Technology Corp Ltd's Retained Earnings amounts to 1.1B CNY.

Back to Top